Acid-Suppressive Efficacy of a Reduced Dosage of Rabeprazole: Comparison of 10 Mg Twice Daily Rabeprazole with 20 Mg Twice Daily Rabeprazole, 30 Mg Twice Daily Lansoprazole, and 20 Mg Twice Daily Omeprazole by 24-Hr Intragastric pH-metry
- 1 July 2005
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 50 (7) , 1202-1206
Abstract
Rabeprazole achieves more potent acid suppression than other proton pump inhibitors. Therefore it is administered at reduced as well as high dosages in eradication therapy for Helicobacter pylori; however, there is incomplete assessment of the efficacy of a reduced dosage of rabeprazole as might be employed in therapy. In this study, we evaluated acid-suppressive efficacy of a reduced dosage of rabeprazole on day 7 by 24-hr pH-metry in 10 healthy male cytochrome P-450 2C19 extensive metabolizers without Helicobacter pylori infection and compared the results with those of high dosages of rabeprazole, lansoprazole, and omeprazole. Median intragastric pH value, pH >3 holding time ratio (pH>3HT), pH>4HT, pH>5HT, pH>6HT, and pH>7HT for 24 hr with rabeprazole, 10 mg twice daily, were not significantly different from those of rabeprazole, 20 mg twice daily, lansoprazole, 30 mg twice daily, and omeprazole, 20 mg twice daily. In conclusion, for acid-suppressive efficacy, a reduced dosage of rabeprazole is comparable to high dosages of rabeprazole, lansoprazole, and omeprazole.Keywords
This publication has 36 references indexed in Scilit:
- Helicobacter pylori eradication increases nocturnal acid breakthroughAlimentary Pharmacology & Therapeutics, 2000
- A placebo‐controlled study to assess the effects of 7‐day dosing with 10, 20 and 40 mg rabeprazole on 24‐h intragastric acidity and plasma gastrin in healthy male subjectsAlimentary Pharmacology & Therapeutics, 2000
- Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazoleGut, 1999
- Prolonged and Profound Acid Inhibition Is Crucial in Helicobacter pylori Treatment with a Proton Pump Inhibitor Combined with AmoxicillinScandinavian Journal of Gastroenterology, 1998
- RabeprazoleDrugs, 1998
- Genetic polymorphism of S-mephenytoin 4??-hydroxylation in African-AmericansPharmacogenetics, 1996
- Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer diseaseGastroenterology, 1995
- Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.Gut, 1995
- Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pyloriJournal of Antimicrobial Chemotherapy, 1994
- Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux DiseaseDigestion, 1992